Friday, July 10, 2026

pharma · Rheumatoid Arthritis · Cholera

International Peace Maternity

International Peace Maternity clinical programs — 7 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
21
Drugs
16
Patents
0
Intelligence · Clinical Programs

International Peace Maternity projects

7 ClinicalTrials.gov programs sponsored by International Peace Maternity.

International Peace Maternity has 7 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Chemotherapy

    International Peace Maternity and Child Health Hospital

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial
  2. Olokizumab

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial
  3. Olokizumab 64 mg SC q4w

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial
  4. Olokizumab 64mg q4w

    International Peace Maternity and Child Health Hospital

    Rheumatoid Arthritis

    phase 3 small molecule completed

    1 trial
  5. Radiotherapy

    International Peace Maternity and Child Health Hospital

    Cervix Cancer

    phase 3 other completed

    1 trial
  6. Tamoxifen

    International Peace Maternity and Child Health Hospital

    Breast Cancer

    phase 3 small molecule completed

    1 trial
  7. ZX008 (Fenfluramine Hydrochloride)

    International Peace Maternity and Child Health Hospital

    Dravet Syndrome

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does International Peace Maternity have?

7 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.